Adven Aims To Start Reprocessing Within Weeks Of Signing Consent Decree
This article was originally published in The Gray Sheet
Executive Summary
FDA auditors are expected to review Adven Medical's Lubbock, Texas facilities the week of Aug. 18, according to the firm